Clovis Oncology, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

Clovis Oncology, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

Clovis Oncology, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $1.49 million as of 2017-09-30, per its 10-Q filed 2017-11-02.

Discontinued › Notes › Intangible Assets › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2017-11-02

• 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.49M.
• 2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.49M.
• 2017-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.49M.